1. Home
  2. CRIS vs STKH Comparison

CRIS vs STKH Comparison

Compare CRIS & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • STKH
  • Stock Information
  • Founded
  • CRIS 2000
  • STKH 2018
  • Country
  • CRIS United States
  • STKH Israel
  • Employees
  • CRIS N/A
  • STKH N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • STKH Packaged Foods
  • Sector
  • CRIS Health Care
  • STKH Consumer Staples
  • Exchange
  • CRIS Nasdaq
  • STKH Nasdaq
  • Market Cap
  • CRIS 22.9M
  • STKH 21.6M
  • IPO Year
  • CRIS 2000
  • STKH 2021
  • Fundamental
  • Price
  • CRIS $1.65
  • STKH $3.75
  • Analyst Decision
  • CRIS Strong Buy
  • STKH
  • Analyst Count
  • CRIS 2
  • STKH 0
  • Target Price
  • CRIS $16.50
  • STKH N/A
  • AVG Volume (30 Days)
  • CRIS 66.6K
  • STKH 1.6M
  • Earning Date
  • CRIS 11-13-2025
  • STKH 11-21-2025
  • Dividend Yield
  • CRIS N/A
  • STKH N/A
  • EPS Growth
  • CRIS N/A
  • STKH N/A
  • EPS
  • CRIS N/A
  • STKH N/A
  • Revenue
  • CRIS $11,405,000.00
  • STKH $10,000.00
  • Revenue This Year
  • CRIS $2.72
  • STKH N/A
  • Revenue Next Year
  • CRIS $8.27
  • STKH N/A
  • P/E Ratio
  • CRIS N/A
  • STKH N/A
  • Revenue Growth
  • CRIS 12.24
  • STKH N/A
  • 52 Week Low
  • CRIS $1.02
  • STKH $3.56
  • 52 Week High
  • CRIS $5.51
  • STKH $132.00
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 42.93
  • STKH 49.36
  • Support Level
  • CRIS $1.58
  • STKH $4.20
  • Resistance Level
  • CRIS $1.74
  • STKH $4.53
  • Average True Range (ATR)
  • CRIS 0.09
  • STKH 0.53
  • MACD
  • CRIS -0.00
  • STKH -0.25
  • Stochastic Oscillator
  • CRIS 17.34
  • STKH 6.45

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: